Best Virology Journals (2026): Ranked by Impact and Accessibility
A ranked guide to the top 12 virology journals by impact factor, acceptance rate, APC, and review time — from Nature Microbiology to accessible OA options for fundamental and clinical virology.
Senior Researcher, Oncology & Cell Biology
Author context
Specializes in manuscript preparation and peer review strategy for oncology and cell biology, with deep experience evaluating submissions to Nature Medicine, JCO, Cancer Cell, and Cell-family journals.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Virology publishing exists in a peculiar position. The field doesn't have many dedicated virology journals, yet virology research is published everywhere, from Nature and Science to infectious disease journals, immunology journals, and even public health titles. The pandemic years of 2020-2023 transformed the publication landscape, flooding journals with COVID-related manuscripts and temporarily inflating impact factors. Things have settled now, but you'll still see lasting effects including greater emphasis on preprints, faster review timelines, and higher editorial expectations for pandemic preparedness research.
Choosing the right virology journal depends heavily on your virus, your methods, and your angle. A structural study of a viral polymerase might belong in Nature Structural & Molecular Biology. An epidemiological study of viral transmission fits in Lancet Infectious Diseases. A detailed characterization of viral replication mechanisms belongs in Journal of Virology. The dedicated virology journals aren't your only option.
Quick Answer: Top 5 Virology Journals
- Nature Microbiology (IF ~20.5) for top-impact virology
- PLOS Pathogens (IF ~6.7) for host-pathogen biology (OA)
- Journal of Virology (IF ~3.8) for fundamental virology
- mBio (IF ~5.1) for broad microbiology including virology
- Emerging Infectious Diseases (IF ~7.2) for surveillance and emerging viruses
Full Comparison Table
Journal | IF | Acceptance Rate | APC | Review Time | Scope |
|---|---|---|---|---|---|
Nature Microbiology | ~20.5 | ~5% | $11,390 (OA option) | 4-8 weeks | All microbiology including virology |
Lancet Infectious Diseases | ~31.0 | <5% | $5,690 (OA option) | 4-8 weeks | Clinical ID, epidemiology |
PLOS Pathogens | ~6.7 | ~15% | $3,040 (OA) | 6-10 weeks | Host-pathogen biology |
Emerging Infectious Diseases | ~7.2 | ~20% | Free OA | 4-8 weeks | Surveillance, emerging pathogens |
mBio | ~5.1 | ~18% | $4,500 (OA) | 4-8 weeks | Broad microbiology |
Journal of Virology | ~3.8 | ~22% | $3,500 (OA option) | 4-8 weeks | Fundamental virology |
Journal of Infectious Diseases | ~5.2 | ~15% | $3,800 (OA option) | 6-10 weeks | Clinical ID research |
Antiviral Research | ~4.5 | ~20% | $3,300 (OA option) | 6-10 weeks | Antiviral drugs, therapeutics |
Viruses | ~3.8 | ~35% | $2,600 (OA) | 4-6 weeks | Broad virology, MDPI |
Virology | ~2.8 | ~30% | $3,400 (OA option) | 6-10 weeks | Fundamental virology |
Journal of General Virology | ~2.7 | ~28% | $2,800 (OA option) | 6-10 weeks | General virology |
Virus Research | ~2.5 | ~30% | $2,800 (OA option) | 6-10 weeks | Broad virology |
Elite Tier: Where the Biggest Virology Papers Land
Nature Microbiology
For virology papers with the highest impact, Nature Microbiology is the leading dedicated venue (alongside Nature and Science for truly field-changing work). The journal publishes virology studies that reveal new mechanisms of infection, immunity, or viral evolution. The bar is high, and most submissions are desk-rejected. But if your virology discovery changes how the field thinks about a fundamental process, this is the target.
Lancet Infectious Diseases
Not a virology journal per se, but Lancet Infectious Diseases publishes the highest-impact clinical virology, including vaccine trials, epidemiological studies, and therapeutic advances. If your virology has direct clinical relevance, this journal provides reach into clinical medicine and public health that specialty journals can't match.
Emerging Infectious Diseases (EID)
Published by the CDC, EID is free OA and focuses on emerging and re-emerging pathogens, surveillance, and outbreak investigation. It's an excellent venue for virological studies of new or resurging viruses, epidemiological analyses, and diagnostics research. The free OA model is a significant advantage, and the CDC association gives papers immediate policy relevance.
Strong Tier: The Core Virology Journals
PLOS Pathogens
This is one of the strongest venues for virology research that focuses on host-pathogen interactions and pathogenesis mechanisms. PLOS Pathogens values mechanistic insight, whether you're studying viral entry, immune evasion, or pathogenesis. It's fully OA and has a strong readership across the microbiology and immunology communities.
mBio
ASM's flagship OA journal regularly publishes high-quality virology. It's a strong choice for virology papers with broad appeal across microbiology. The editorial team is responsive, and the review process is fair. If your virology paper has implications beyond virology (evolutionary biology, immunology, public health), mBio is an excellent target.
Journal of Virology (JVI)
JVI is the most established dedicated virology journal and the ASM's virology flagship. It covers all aspects of virology, from molecular virology to pathogenesis, from plant viruses to human pathogens. While its IF is lower than some competitors, JVI's volume, indexing, and readership make it the central journal for the virology community. A JVI paper reaches virtually every virologist. The review process typically involves genuine experts in your specific virus family.
Journal of Infectious Diseases
IDSA's journal publishes clinical and translational virology alongside broader infectious disease research. It's a strong venue for studies connecting viral biology to clinical outcomes, vaccine responses, and antiviral efficacy. If your virology has a clinical translation angle, JID provides the right audience.
Antiviral Research
The leading journal for antiviral drug development, resistance mechanisms, and therapeutic strategies. If your paper describes a new antiviral compound, characterizes drug resistance, or evaluates therapeutic approaches, Antiviral Research has the most relevant readership. It's particularly valued by the pharmaceutical virology community.
Accessible Tier: Broad Options
Viruses
This MDPI journal has grown rapidly and publishes broadly across virology. The acceptance rate is higher than ASM journals, and the review timeline is typically fast. The journal covers all virus families and all aspects of virology. While MDPI journals face some skepticism, Viruses is well-indexed and has a stable readership. It's a pragmatic option for solid virology studies.
Virology
An Elsevier journal with a long history in fundamental virology. It publishes original research on all viruses and covers molecular virology, structural virology, and virus-host interactions. The journal is less competitive than JVI and provides a respectable home for well-executed studies that don't reach JVI's novelty threshold.
Journal of General Virology
The Microbiology Society's virology journal covers general virology with a slight UK and European author base. It publishes solid original research across all virus families and is a reasonable target for studies that provide incremental but genuine advances in understanding viral biology.
Virus Research
An Elsevier journal that publishes across all virology. It's accessible for well-designed studies and provides steady indexing and visibility. A practical choice for studies that need a publication home without the extended review processes of more competitive journals.
Decision Framework: Matching Your Virology Paper
If your paper reveals a new mechanism of viral infection or immunity, Nature Microbiology or PLOS Pathogens are the targets. Both want mechanistic insight, not descriptive work.
If your paper is a clinical virology study (vaccine trial, therapeutic evaluation), Lancet Infectious Diseases or Journal of Infectious Diseases are appropriate. Match the impact level to the journal's selectivity.
If your paper involves an emerging or novel pathogen, Emerging Infectious Diseases is ideal and offers free OA. mBio also welcomes emerging pathogen studies.
If your paper is fundamental molecular virology, Journal of Virology is the community journal. Virology and Journal of General Virology are accessible alternatives.
If your paper develops or evaluates antiviral compounds, Antiviral Research is the specialist venue.
If your paper needs accessible OA, Viruses offers fast turnaround. mBio offers higher prestige with OA.
Common Mistakes in Virology Journal Selection
Defaulting to Journal of Virology for everything. JVI is excellent for fundamental virology, but clinical virology papers, epidemiological studies, and immunology-heavy papers often fit better elsewhere. Consider the angle before committing.
Ignoring cross-disciplinary journals. A virology paper about immune evasion might fit better in Journal of Experimental Medicine or Immunity. A structural virology paper might belong in Structure. Don't limit yourself to virology titles.
Underestimating Emerging Infectious Diseases. EID has a strong IF, free OA, and direct policy influence through its CDC connection. For surveillance, diagnostics, and outbreak research, it's hard to beat.
Submitting pandemic-era work without updating the context. The publishing landscape has moved on from the acute pandemic phase. Editors now expect COVID-related work to provide novel insights beyond what was published during the initial surge.
Not considering preprints. Virology embraced preprints during the pandemic, and most journals now accept preprinted manuscripts. Posting on bioRxiv or medRxiv protects priority in a fast-moving field.
Sending clinical virology to basic science journals. JVI and Virology want molecular and cellular data. If your paper is about clinical outcomes, transmission dynamics, or public health impact, infectious disease journals are better fits.
Refine Your Manuscript
Virology reviewers are detail-oriented and expect proper biosafety documentation, sequence accession numbers, and reproducible experimental descriptions. Before submitting, use Manusights' AI review to ensure your manuscript meets journal-specific requirements, your statistical methods are clearly reported, and your figures meet publication standards. Small preparation steps make a measurable difference in review outcomes.
Sources
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.